ACT (OCATA) – October 2013

ACT (Advanced Cell Technology) (Now: OCATA)
Corporate video – October 2013

Members of ACT’s Senior Executive Leadership team discuss
the cutting-edge science and technology that drives the company’s mission of developing novel therapies from embryo-safe stem cell technologies to bring patient-specific therapies from the lab bench to the bedside.

Featuring:
Gary Rabin, Chairman and Chief Executive Officer
Robert Lanza, M.D., Chief Scientific Officer
Ted Myles, CFO and Executive Vice President of Corporate Development
Matthew Vincent, Ph.D., Director of Business Development

source